57
Views
38
CrossRef citations to date
0
Altmetric
RAPID COMMUNICATION

Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis

, , , , , , , , , , & show all
Pages 531-533 | Received 22 May 2007, Accepted 26 Jun 2007, Published online: 02 Jan 2014

References

  • Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D, et al. Vac-cination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFec blockers. Ann Rheum Dis 2006;65:191–4.
  • Kapetanovic MC, Saxne T, Nilsson JA, Pistoor F, Geborek P. Influ-enza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Ftheumatology 2007;46:608–11.
  • Kaine J, Kivitz A, Birbara C, Luo AY. Abilities to develop protective antibodies to pneumococcal and influenza vaccine are maintained in rheumatoid arthritis patients treated with adalimumab (Humira). Arthritis Rheum 2006;54:S515–6.
  • Herron A, Dettleff G, Hixon B, Brandwin L, Ortbals D, Hornick R, et al. Influenza vaccination in patients with rheumatic diseases: safety and efficacy. JAMA 1979;242:53–6.
  • Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor a monoclonal antibody com-bined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552–63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.